AI-Powered Blood Test Enhances Early Detection of Ovarian Cancer
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Category: Unknown Origin & Other Cancer Types
Unknown Origin & Other Cancer Types
Latest
Unknown Origin & Other Cancer Types
Latest
Rapid Cerebrospinal Fluid Test Decreases Time for Brain Tumors Diagnosis
A new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Unknown Origin & Other Cancer Types
Latest
Myriad Genetics Receives Patent for High-Definition MRD Assay
The U.S. Patent and Trademark Office issued a patent to Myriad Genetics aimed at strengthening its ability to deliver a MRD assay to market.Â
Researchers Use Liquid Biopsies to Detect Relapse of Childhood Cancer Early
The study will collect small blood samples several times from 150 patients with high-risk neuroblastoma to be examined in laboratories.
Read More
Protein Biomarker Identified for Aggressive Neuroendocrine Carcinomas Diagnosis
New research is guiding the development of blood tests to detect and monitor responses to therapies in neuroendocrine carcinomas patients.
Read More
Test to Guide Radiation Therapy for Skin Cancer Patients Could Save Millions in Medicare Costs
The DecisionDx-SCC test guides adjuvant radiation therapy (ART) decisions for patients with squamous cell carcinoma (SCC).
Read More
Brush Biopsy Enables Early Oral Cancer Detection
Researchers invented a new test that uses a small brush to allow dentists to screen for the most common form of oral cancer.
Read More
Obesity Linked to Detection of Blood Cancer Precursor
Individuals with obesity are more likely to have MGUS, a benign blood condition that often precedes multiple myeloma.
Read More
Hepatocellular Carcinoma Diagnosis May be Improved with AI
Recent advancements in AI, including deep learning, offer significant potential for improving hepatocellular carcinoma diagnosis.
Read More
Automated Liquid Biopsy Detects Brain Tumor Cells in Children
Researchers wanted to see if a liquid biopsy tool could capture and isolate CTCs in blood samples taken from children with CNS tumors.
Read More
Cancer Test May Help Bring Benefits of Immunotherapy to More Patients
Findings from NGS suggest that revising cancer care guidelines could allow many more patients to benefit from immunotherapy treatment.
Read More
Liver Cancer Screening Rates Doubled With Mailed Orders
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist.
Read More
Collaboration Aims to Develop AI Diagnostic Tools for Urology
This collaboration aims to deliver AI diagnostic tools that aid urologists in the detection, surgery, and post-treatment surveillance.
Read More
FDA Clears Beckman Coulter’s Stem Cell Analysis System
Beckman Coulter Life Sciences received 510(k) clearance from the FDA to distribute its AQUIOS STEM System in the United States.
Read More
Moffitt Gets Grant to Evaluate Oropharyngeal Cancer Test
The $3.6 million grant aims to further research on a noninvasive diagnostic biomarker panel for the early detection of oropharyngeal cancer.
Read More
Lucid Diagnostics Launches Next-Gen Esophageal DNA Test
Lucid Diagnostics launched the next generation of its Esophageal DNA test for the detection of esophageal precancer.
Read More
Skin Cancer Diagnoses Using AI are Reliable
A research team investigated the extent to which diagnosis and therapy of pigmented skin lesions benefit from AI in a clinical scenario.Â
Read More
Aventa Genomics Launches 3D Genomics Test for Patients with Tumors
The new NGS test detects gene fusions, translocations, and rearrangements across 361 genes from FFPE tumor tissue.Â
Read More